AgomAb Therapeutics
Ellen joined AgomAb as General Counsel in 2021. She previously served as Deputy General Counsel at Galapagos. In this role, she led the corporate law department and advised on all corporate development activities, including the company’s Nasdaq IPO and secondary offerings. Prior to this, she worked at corporate law firms Linklaters, Simpson, Thacher & Bartlett and Eubelius where she focused on M&A and capital markets transactions. Ellen holds an LL.M. in Corporate Governance & Practice from Stanford Law School and a master’s degree in law from the University of Leuven. She is qualified to practice in Belgium and New York.
This person is not in any offices
AgomAb Therapeutics
AgomAb is pioneering therapies that modulate regenerative pathways to achieve structural tissue repair and functional organ recovery.